Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07663266 · ClinicalTrials.gov registry record
Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury
A clinical trial, sponsored by University of Michigan.
- Recruiting
- Registry status
- 14
- Enrollment target
NCT07663266: Recruiting study, sponsored by University of Michigan.
NCT07663266 is a clinical trial that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07663266 is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 14 participants
- Enrollment target
Study Summary
Just-In-Time Adaptive Interventions (JITAIs) offer a framework for delivering personalized behavioral support using time-varying data to optimize the timing and type of intervention content. This project will develop the foundational components of a JITAI tailored to adults with chronic pain and either MS or SCI by drawing on symptom self-management content from existing programs (PainGuide, MyMSToolkit, and MySCIToolkit). Intervention content and delivery parameters will be refined through stakeholder engagement via structured interviews to ensure relevance, acceptability, and feasibility.
Primary Outcome
Participant preferences for the JITAI push notification content and delivery assessed via interviews. The primary outcome will be assessed with qualitative data analyses, which will be used to inform push notification content for a JITAI to support chronic pain self-management in adults with MS and adults with SCI.
Interventions
- OTHER Push Notification Content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2026-05-25 |
| Est. Completion | 2026-07 |
What NCT07663266 shows while recruiting
NCT07663266 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Push Notification Content is the first listed.
NCT07663266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07663266 about?
NCT07663266 is a clinical study titled "Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury". Just-In-Time Adaptive Interventions (JITAIs) offer a framework for delivering personalized behavioral support using time-varying data to optimize the timing and type of intervention content. This project will develop the foundational components of a JITAI tailored to adults with chronic pain and eit...
What is the current status of trial NCT07663266?
This trial is currently recruiting. The enrollment target is 14 participants. The study started on 2026-05-25. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07663266?
The interventions under investigation include: Push Notification Content (OTHER).
Who is sponsoring clinical trial NCT07663266?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy